Company profile
ArriVent BioPharma, Inc. Insider Trading
AVBPEvery SEC Form 4 insider trading filing for ArriVent BioPharma, Inc. (AVBP) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001868279
- Filings
- 30
- Insiders
- 18
- Last filing
- 2026-06-18
Activity summary
No insider transactions in the last 30 days. The most recent was on June 18, 2026, when Chris Nolet bought 13,562 shares. 30 filings from 18 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q1 24 to Q2 26. ArriVent BioPharma, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $34.0M.
No insider activity recorded for AVBP in the last 90 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | Chris Nolet | AVBP | Award | 13,562 | — | — |
| Jun 18, 2026 | John Hohneker | AVBP | Award | 13,562 | — | — |
| Jun 18, 2026 | Kristine Peterson | AVBP | Award | 13,562 | — | — |
| Jun 18, 2026 | Merdad Parsey | AVBP | Award | 13,562 | — | — |
| Feb 2, 2026 | James Paul Kastenmayer | AVBP | Award | 130,000 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=AVBP" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of ArriVent BioPharma, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →